Jamie Dananberg
CIK 1734424 · CHIEF MEDICAL OFFICER · last filed 2026-03-04
Jamie Dananberg is a CHIEF MEDICAL OFFICER who has filed 30 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider sold $31.6K of ANNX on Mar 4, 2026. Across all open-market trades the lifetime net is −$96.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $582.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$582.1K
2
30
-$96.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANNX | CHIEF MEDICAL OFFICER | 123,582 | $4.71 | $582.1K | -$74.9K | 7 | 2026-03-04 |
| Unity Biotechnology, Inc. (UBX) Delisted | Chief Medical Officer | 62,817 | $0.20 | $12.6K | -$21.9K | 23 | 2023-04-03 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | ANNX | Sell (S) | −5,820 | -$31.6K | EDGAR |
| 2026-02-23 | ANNX | Grant (A) | +56,250 | $0 | EDGAR |
| 2026-02-20 | ANNX | Sell (S) | −5,290 | -$27.0K | EDGAR |
| 2025-03-03 | ANNX | Grant (A) | +44,963 | $0 | EDGAR |
| 2025-02-20 | ANNX | Sell (S) | −5,521 | -$16.3K | EDGAR |
| 2024-02-21 | ANNX | Grant (A) | +39,000 | $0 | EDGAR |
| 2023-08-02 | ANNX | Grant (A) | — | $0 | EDGAR |
| 2023-04-03 | Unity Biotechnology, Inc. (UBX) Delisted | Sell (S) | −420 | -$714 | EDGAR |
| 2023-03-15 | Unity Biotechnology, Inc. (UBX) Delisted | Sell (S) | −1,005 | -$4.0K | EDGAR |
| 2023-02-03 | Unity Biotechnology, Inc. (UBX) Delisted | Sell (S) | −863 | -$4.2K | EDGAR |